Flavonoid-type compounds (e.g., GPM10, GPM15, GPM23) were predominantly associated with inflammation-related targets such as TNF, NOS2, EGFR, and IL2, and enriched in signaling pathways related to immune modulation and infection control, including cytokine signaling, tuberculosis, and influenza pathways. The gene discussed is NOS2; the disease is influenza.